
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
Author(s) -
Keira Markey,
Ryan Ottridge,
James Mitchell,
Caroline Rick,
Rebecca Woolley,
Natalie Ives,
Peter Nightingale,
Alexandra J Sinclair
Publication year - 2017
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/resprot.7806
Subject(s) - medicine , randomized controlled trial , drug , pharmacology , clinical trial , safety profile , adverse effect